Noninvasive blood glucose monitoring with optical coherence tomography: A pilot study in human subjects

Kirill V. Larin, Mohsen S. Eledrisi, Massoud Motamedi, Rinat Esenaliev

Research output: Contribution to journalArticle

216 Citations (Scopus)

Abstract

OBJECTIVE - To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers. RESEARCH DESIGN AND METHODS - An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10-20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200-600 μm from the skin surface. RESULTS - A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8% per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers. CONCLUSIONS - This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.

Original languageEnglish (US)
Pages (from-to)2263-2267
Number of pages5
JournalDiabetes Care
Volume25
Issue number12
DOIs
StatePublished - Dec 2002

Fingerprint

Optical Coherence Tomography
Blood Glucose
Healthy Volunteers
Feasibility Studies
Glucose Tolerance Test
Photons
Forearm
Veins
Arm
Research Design
Glucose
Skin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Noninvasive blood glucose monitoring with optical coherence tomography : A pilot study in human subjects. / Larin, Kirill V.; Eledrisi, Mohsen S.; Motamedi, Massoud; Esenaliev, Rinat.

In: Diabetes Care, Vol. 25, No. 12, 12.2002, p. 2263-2267.

Research output: Contribution to journalArticle

@article{ef726b80fb6f4be5b66b19ff46ea6f87,
title = "Noninvasive blood glucose monitoring with optical coherence tomography: A pilot study in human subjects",
abstract = "OBJECTIVE - To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers. RESEARCH DESIGN AND METHODS - An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10-20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200-600 μm from the skin surface. RESULTS - A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8{\%} per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers. CONCLUSIONS - This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.",
author = "Larin, {Kirill V.} and Eledrisi, {Mohsen S.} and Massoud Motamedi and Rinat Esenaliev",
year = "2002",
month = "12",
doi = "10.2337/diacare.25.12.2263",
language = "English (US)",
volume = "25",
pages = "2263--2267",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "12",

}

TY - JOUR

T1 - Noninvasive blood glucose monitoring with optical coherence tomography

T2 - A pilot study in human subjects

AU - Larin, Kirill V.

AU - Eledrisi, Mohsen S.

AU - Motamedi, Massoud

AU - Esenaliev, Rinat

PY - 2002/12

Y1 - 2002/12

N2 - OBJECTIVE - To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers. RESEARCH DESIGN AND METHODS - An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10-20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200-600 μm from the skin surface. RESULTS - A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8% per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers. CONCLUSIONS - This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.

AB - OBJECTIVE - To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers. RESEARCH DESIGN AND METHODS - An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10-20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200-600 μm from the skin surface. RESULTS - A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8% per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers. CONCLUSIONS - This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.

UR - http://www.scopus.com/inward/record.url?scp=0038628894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038628894&partnerID=8YFLogxK

U2 - 10.2337/diacare.25.12.2263

DO - 10.2337/diacare.25.12.2263

M3 - Article

C2 - 12453971

AN - SCOPUS:0038628894

VL - 25

SP - 2263

EP - 2267

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 12

ER -